SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-005307
Filing Date
2023-08-15
Accepted
2023-08-15 06:00:10
Documents
6
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081423.htm 6-K 6980
2 EXHIBIT 99.1 exh_991.htm EX-99.1 466902
3 EXHIBIT 99.2 exh_992.htm EX-99.2 241941
4 EXHIBIT 99.3 exh_993.htm EX-99.3 10780
5 EXHIBIT 99.4 exh_994.htm EX-99.4 10687
6 GRAPHIC logo.jpg GRAPHIC 5293
  Complete submission text file 0001171843-23-005307.txt   745712
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 231173088
SIC: 2834 Pharmaceutical Preparations